Please login to the form below

Not currently logged in

Finalists decided in UK cancer awards

QiC Excellence in Oncology aims to recognise good practice in cancer care throughout UK

QiC Excellence in Oncology

Finalists for the first QiC Excellence in Oncology awards have been announced, each demonstrating an example of good practice in cancer care throughout the UK.

In total, there are 39 finalists spanning 10 categories, including the cancer commissioning award, cancer team of the year and patient experience.

Represented among the finalists in cancer charity initiative of the year were Macmillan Cancer Support, testicular cancer awareness campaign It's in the Bag and HeadSmart to raise awareness of brain tumours.

And those down to final five for cancer journalist of blogger of the year included Linda Geddes of New Scientist, freelance writer Judy Hobson and cancer blogger Mike Baker.

QiC Excellence in Oncology is an evolution of Pfizer's Excellence in Oncology awards, and aims to recognise individuals or teams involved in the support, care and treatment of cancer patients in the UK.

It is supported by Cancer 52, Beating Bowel Cancer, the National Cancer Action Team, and has industry partners such as Pfizer, BMS and Novartis.

Winners will be announced on November 6 at The Hilton, Liverpool, during the National Cancer Research Institute's (NCRI) annual conference.

14th September 2012



Featured jobs

Subscribe to our email news alerts


Add my company
E-lixir Consulting

E-lixir offers digital solutions and consulting for events and trainings. We design the most customised applications for congresses, events, sales...

Latest intelligence

Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...
Medius Deal Watch
Deal Watch September 2016
Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up...